Oxidative Stress and Hippocampal Synaptic Protein Levels in Elderly Cognitively Intact Individuals with Alzheimer's Disease Pathology

Overview

Journal Neurobiol Aging

Publisher Elsevier

Specialties Geriatrics
Neurology
Physiology

Date 2016 May 5

PMID 27143416

Citations 43

Authors

Stephen W Scheff

Mubeen A Ansari

Elliott J Mufson

Affiliations

Soon will be listed here.

Abstract

Neuritic amyloid plaques and neurofibrillary tangles are hallmarks of Alzheimer's disease (AD) and are major components used for the clinical diagnosis of this disorder. However, many individuals with no cognitive impairment (NCI) also present at autopsy with high levels of these AD pathologic hallmarks. In this study, we evaluated 15 autopsy cases from NCI individuals with high levels of AD-like pathology (high pathology no cognitive impairment) and compared them to age- and postmortem-matched cohorts of individuals with amnestic mild cognitive impairment and NCI cases with low AD-like pathology (low pathology no cognitive impairment [LPNCI]). Individuals classified as high pathology no cognitive impairment or amnestic mild cognitive impairment had a significant loss of both presynaptic and postsynaptic proteins in the hippocampus compared with those in the LPNCI cohort. In addition, these 2 groups had a significant increase in 3 different markers of oxidative stress compared with that in the LPNCI group. The changes in levels of synaptic proteins are strongly associated with levels of oxidative stress. These data suggest that cognitively older subjects without dementia but with increased levels of AD-like pathology may represent a very early preclinical stage of AD.

Citing Articles

Recent advancements in the understanding of the alterations in mitochondrial biogenesis in Alzheimer's disease.

Singh S, Singh R Mol Biol Rep. 2025; 52(1):173.

PMID: 39880979 DOI: 10.1007/s11033-025-10297-6.

Exploring the Dynamic Changes of Brain Lipids, Lipid Rafts, and Lipid Droplets in Aging and Alzheimer's Disease.

Cerasuolo M, Di Meo I, Auriemma M, Paolisso G, Papa M, Rizzo M Biomolecules. 2024; 14(11).

PMID: 39595539 PMC: 11591903. DOI: 10.3390/biom14111362.

SV2A PET shows hippocampal synaptic loss in cognitively unimpaired APOE ε4/ε4 homozygotes.

Snellman A, Tuisku J, Koivumaki M, Wahlroos S, Aarnio R, Rajander J Alzheimers Dement. 2024; 20(12):8802-8813.

PMID: 39475191 PMC: 11667521. DOI: 10.1002/alz.14327.

Psilocybin for the treatment of Alzheimer's disease.

Zheng S, Ma R, Yang Y, Li G Front Neurosci. 2024; 18:1420601.

PMID: 39050672 PMC: 11266071. DOI: 10.3389/fnins.2024.1420601.

Fucoidan Improves D-Galactose-Induced Cognitive Dysfunction by Promoting Mitochondrial Biogenesis and Maintaining Gut Microbiome Homeostasis.

Xu Y, Xue M, Li J, Ma Y, Wang Y, Zhang H Nutrients. 2024; 16(10).

PMID: 38794753 PMC: 11124141. DOI: 10.3390/nu16101512.

References

Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R . Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003; 329(1-2):23-38. DOI: 10.1016/s0009-8981(03)00003-2. View

Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

DeKosky S, Ikonomovic M, Styren S, Beckett L, Wisniewski S, Bennett D . Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002; 51(2):145-55. DOI: 10.1002/ana.10069. View

Jellinger K, Attems J . Neuropathology and general autopsy findings in nondemented aged subjects. Clin Neuropathol. 2012; 31(2):87-98. DOI: 10.5414/np300418. View

Mufson E, Mahady L, Waters D, Counts S, Perez S, DeKosky S . Hippocampal plasticity during the progression of Alzheimer's disease. Neuroscience. 2015; 309:51-67. PMC: 4567973. DOI: 10.1016/j.neuroscience.2015.03.006. View

Dickson D, Kouri N, Murray M, Josephs K . Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci. 2011; 45(3):384-9. PMC: 3208128. DOI: 10.1007/s12031-011-9589-0. View

Arriagada P, Marzloff K, Hyman B . Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 1992; 42(9):1681-8. DOI: 10.1212/wnl.42.9.1681. View

Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P . Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988; 23(2):138-44. DOI: 10.1002/ana.410230206. View

Schmitt F, Nelson P, Abner E, Scheff S, Jicha G, Smith C . University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res. 2012; 9(6):724-33. PMC: 3409295. DOI: 10.2174/156720512801322591. View

10.

Gao H, Zhou H, Hong J . NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Pharmacol Sci. 2012; 33(6):295-303. PMC: 3477578. DOI: 10.1016/j.tips.2012.03.008. View

11.

Walsh D, Selkoe D . A beta oligomers - a decade of discovery. J Neurochem. 2007; 101(5):1172-84. DOI: 10.1111/j.1471-4159.2006.04426.x. View

12.

Schmitt F, Davis D, Wekstein D, Smith C, Ashford J, Markesbery W . "Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology. 2000; 55(3):370-6. DOI: 10.1212/wnl.55.3.370. View

13.

Ighodaro E, Jicha G, Schmitt F, Neltner J, Abner E, Kryscio R . Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature. J Neuropathol Exp Neurol. 2015; 74(7):642-52. PMC: 4539239. DOI: 10.1097/NEN.0000000000000204. View

14.

Scheff S, Price D, Schmitt F, Scheff M, Mufson E . Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2011; 24(3):547-57. PMC: 3098316. DOI: 10.3233/JAD-2011-101782. View

15.

Darwish R, Amiridze N, Aarabi B . Nitrotyrosine as an oxidative stress marker: evidence for involvement in neurologic outcome in human traumatic brain injury. J Trauma. 2007; 63(2):439-42. DOI: 10.1097/TA.0b013e318069178a. View

16.

Luque-Contreras D, Carvajal K, Toral-Rios D, Franco-Bocanegra D, Campos-Pena V . Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease?. Oxid Med Cell Longev. 2014; 2014:497802. PMC: 3941786. DOI: 10.1155/2014/497802. View

17.

Nelson P, Alafuzoff I, Bigio E, Bouras C, Braak H, Cairns N . Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012; 71(5):362-81. PMC: 3560290. DOI: 10.1097/NEN.0b013e31825018f7. View

18.

Nag S, Yu L, Capuano A, Wilson R, Leurgans S, Bennett D . Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol. 2015; 77(6):942-52. PMC: 4447563. DOI: 10.1002/ana.24388. View

19.

Counts S, He B, Nadeem M, Wuu J, Scheff S, Mufson E . Hippocampal drebrin loss in mild cognitive impairment. Neurodegener Dis. 2012; 10(1-4):216-9. PMC: 3363353. DOI: 10.1159/000333122. View

20.

Bouras C, Hof P, Giannakopoulos P, Michel J, Morrison J . Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex. 1994; 4(2):138-50. DOI: 10.1093/cercor/4.2.138. View